Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 23914343)

1.

Facile Synthesis of PEGylated PLGA Nanoparticles Encapsulating Doxorubicin and its In Vitro Evaluation as Potent Drug Delivery Vehicle.

Kumar R, Kulkarni A, Nabulsi J, Nagesha DK, Cormack R, Makrigiorgos MG, Sridhar S.

Drug Deliv Transl Res. 2013 Aug 1;3(4):299-308. doi: 10.1007/s13346-012-0124-9.

2.

Preparation and in vitro evaluation of doxorubicin-loaded Fe₃O₄ magnetic nanoparticles modified with biocompatible copolymers.

Akbarzadeh A, Mikaeili H, Zarghami N, Mohammad R, Barkhordari A, Davaran S.

Int J Nanomedicine. 2012;7:511-26. doi: 10.2147/IJN.S24326. Epub 2012 Feb 1.

3.

Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method.

Kashi TS, Eskandarion S, Esfandyari-Manesh M, Marashi SM, Samadi N, Fatemi SM, Atyabi F, Eshraghi S, Dinarvand R.

Int J Nanomedicine. 2012;7:221-34. doi: 10.2147/IJN.S27709. Epub 2012 Jan 10.

4.

Development and optimization of doxorubicin loaded poly(lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cells.

Deng L, Li L, Yang H, Li L, Zhao F, Wu C, Liu Y.

J Nanosci Nanotechnol. 2014 Apr;14(4):2947-54.

PMID:
24734715
5.

Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.

Niu X, Zou W, Liu C, Zhang N, Fu C.

Drug Dev Ind Pharm. 2009 Nov;35(11):1375-83. doi: 10.3109/03639040902939221.

PMID:
19832638
6.

Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.

Nair K L, Jagadeeshan S, Nair SA, Kumar GS.

Int J Nanomedicine. 2011;6:1685-97. doi: 10.2147/IJN.S20165. Epub 2011 Aug 17.

7.

Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance.

Zhu H, Chen H, Zeng X, Wang Z, Zhang X, Wu Y, Gao Y, Zhang J, Liu K, Liu R, Cai L, Mei L, Feng SS.

Biomaterials. 2014 Feb;35(7):2391-400. doi: 10.1016/j.biomaterials.2013.11.086. Epub 2013 Dec 19.

PMID:
24360574
8.

Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies.

Sanna V, Roggio AM, Posadino AM, Cossu A, Marceddu S, Mariani A, Alzari V, Uzzau S, Pintus G, Sechi M.

Nanoscale Res Lett. 2011 Mar 28;6(1):260. doi: 10.1186/1556-276X-6-260.

9.

In vitro evaluation of theranostic polymeric micelles for imaging and drug delivery in cancer.

Kumar R, Kulkarni A, Nagesha DK, Sridhar S.

Theranostics. 2012;2(7):714-22. doi: 10.7150/thno.3927. Epub 2012 Jul 31.

10.

Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation.

Betancourt T, Brown B, Brannon-Peppas L.

Nanomedicine (Lond). 2007 Apr;2(2):219-32.

PMID:
17716122
11.

Encapsulation of alpha-1 antitrypsin in PLGA nanoparticles: in vitro characterization as an effective aerosol formulation in pulmonary diseases.

Pirooznia N, Hasannia S, Lotfi AS, Ghanei M.

J Nanobiotechnology. 2012 May 20;10:20. doi: 10.1186/1477-3155-10-20.

12.

High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.

Cun D, Jensen DK, Maltesen MJ, Bunker M, Whiteside P, Scurr D, Foged C, Nielsen HM.

Eur J Pharm Biopharm. 2011 Jan;77(1):26-35. doi: 10.1016/j.ejpb.2010.11.008. Epub 2010 Nov 18.

PMID:
21093589
13.

PEGylated PLGA nanoparticles for the improved delivery of doxorubicin.

Park J, Fong PM, Lu J, Russell KS, Booth CJ, Saltzman WM, Fahmy TM.

Nanomedicine. 2009 Dec;5(4):410-8. doi: 10.1016/j.nano.2009.02.002. Epub 2009 Mar 31.

14.

Novel drug delivery system based on doxorubicin-encapsulated magnetic nanoparticles modified with PLGA-PEG1000 copolymer.

Ebrahimi E, Akbarzadeh A, Abbasi E, Khandaghi AA, Abasalizadeh F, Davaran S.

Artif Cells Nanomed Biotechnol. 2014 Aug 11:1-8. [Epub ahead of print]

PMID:
25111052
15.

pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery.

Zheng J, Tian X, Sun Y, Lu D, Yang W.

Int J Pharm. 2013 Jun 25;450(1-2):296-303. doi: 10.1016/j.ijpharm.2013.04.014. Epub 2013 Apr 15.

PMID:
23598077
16.

AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.

Aravind A, Jeyamohan P, Nair R, Veeranarayanan S, Nagaoka Y, Yoshida Y, Maekawa T, Kumar DS.

Biotechnol Bioeng. 2012 Nov;109(11):2920-31. doi: 10.1002/bit.24558. Epub 2012 Jun 1.

PMID:
22615073
17.

PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.

Ma W, Chen M, Kaushal S, McElroy M, Zhang Y, Ozkan C, Bouvet M, Kruse C, Grotjahn D, Ichim T, Minev B.

Int J Nanomedicine. 2012;7:1475-87. doi: 10.2147/IJN.S29506. Epub 2012 Mar 15.

18.

Anticancer Activity of Nanoparticles Based on PLGA and its Co-polymer: In-vitro Evaluation.

Amjadi I, Rabiee M, Hosseini MS.

Iran J Pharm Res. 2013 Fall;12(4):623-34.

19.

A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery.

Liu Y, Li K, Liu B, Feng SS.

Biomaterials. 2010 Dec;31(35):9145-55. doi: 10.1016/j.biomaterials.2010.08.053. Epub 2010 Sep 22.

PMID:
20864169
20.

Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules.

Chavanpatil MD, Khdair A, Panyam J.

Pharm Res. 2007 Apr;24(4):803-10. Epub 2007 Feb 21.

PMID:
17318416
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk